We also have enough funds to get grant and charity funding for Xanamem to be used in Parkinsons disease and cognitive decline in type II diabetes(where the precursor for Xanamem showed it worked in elderly patients to reverse their memory loss and improve their cognition). Xanamem originally received $25m of funding from the charity Wellcome trust so I can imagine what other medical charities such as the Michael J. Fox foundation will want to come in now to get this to market for other diseases. It is easy for these guys to back such a great management team lead by the former Pfizer CEO of Aus and the guy that ran the no.1 selling Alzheimer’s drug today Aricept phase III study at Pfizer.
We have no competition in cortisol inhibition in Alzheimer’s so let’s go for world domination as fast as we can.
We also have enough funds to get grant and charity funding for...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $105.7M | |||
| Open | High | Low | Value | Volume |
| 3.9¢ | 4.2¢ | 3.9¢ | $194.3K | 4.866M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 2601445 | 3.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.0¢ | 381458 | 3 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| ACW (ASX) Chart |